MTU Cork Library Catalogue

Syndetics cover image
Image from Syndetics

Current topics in SARS-CoV-2/COVID-19 [electronic book] : two years after / edited by Alfonso J. Rodriguez-Morales.

Contributor(s): Rodriguez-Morales, Alfonso J [editor].
Material type: materialTypeLabelBookSeries: IntechOpen Series Infectious Diseases 18.Publisher: London : IntechOpen, 2023Copyright date: ©2023Description: online resource (360 pages).Content type: text Media type: computer Carrier type: online resourceISBN: 9781803562339 (paperback); 9781803562353 (e-Book).Subject(s): COVID-19 (Disease) | EpidemiologyDDC classification: 614.4 Online resources: e-Book
Contents:
Lessons from SARS-CoV-2/COVID-19 after two years of pandemic -- Analysis of SARS-CoV-2 indirect spreading routes and possible countermeasures -- COVID-19 behind ground glasses -- SARS-CoV-2 variants - two years post-onset of the pandemic -- SARS-CoV-2 mutation mechanisms, features, and future perspective -- Panama: scope and psychosocial challenges two years after the COVID-19 pandemic -- Emerging SARS-CoV-2 variants of concern (VOCs) and their impact on transmission rate, disease severity and breakthrough infections -- SARS-C oV-2 variant surveillance in genomic medicine era -- Advances in diagnosis and treatment for SARS-CoV-2 variants -- Novel diagnostics methods for SARS-CoV-2 -- Microfluidic technologies for on-site detection and quantification of infectious diseases - the experience with SARS-CoV-2/COVID-19 -- Recent progressions on the colorimetric diagnosis of SARS-CoV-2 by Loop-Mediated Isothermal Amplification (LAMP) assay -- Bioinformatics study o the evolution of SARS-CoV-2 spike protein -- Real-time genomic surveillance for SARS-CoV-2 on center stage -- Emergency COVID-19 guidelines impacts on the human microbiome and immune system -- Ethics of using placebo controlled trials for COVID-19 vaccine development in vulnerable populations -- Tracking trails of SARS-CoV-2 - variants to therapy -- SARS-CoV-2 pandemic : how to maintain a COVID free hospital.
Summary: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has probably been the most important disease to emerge in the 21st century. This viral zoonotic disease has been a significant cause of morbidity and mortality worldwide, but with a higher impact in low- and middle-income countries of Africa, Asia, and Latin America. Up to December 4, 2022, more than 645,195,564 cases had been reported globally, with 6,640,845 deaths, and more than 13,054,668,703 doses of a vaccine had been given. Research has been of the utmost importance in the COVID-19 crisis: a great deal of knowledge was gathered between December 2019 and December 2022. Appropriate evidence-based management and the development of safe and effective vaccines have been key to controlling the virus. This book presents a selection of the last two years' learning from research and clinical practice concerning SARS-CoV-2/COVID-19.
List(s) this item appears in: Sustainable Development Goals Collection
Holdings
Item type Current library Call number Status Date due Barcode Item holds
e-BOOK MTU Bishopstown Library eBook 614.4 (Browse shelf(Opens below)) Not for loan
Total holds: 0

Includes bibliographical references and index.

Lessons from SARS-CoV-2/COVID-19 after two years of pandemic -- Analysis of SARS-CoV-2 indirect spreading routes and possible countermeasures -- COVID-19 behind ground glasses -- SARS-CoV-2 variants - two years post-onset of the pandemic -- SARS-CoV-2 mutation mechanisms, features, and future perspective -- Panama: scope and psychosocial challenges two years after the COVID-19 pandemic -- Emerging SARS-CoV-2 variants of concern (VOCs) and their impact on transmission rate, disease severity and breakthrough infections -- SARS-C oV-2 variant surveillance in genomic medicine era -- Advances in diagnosis and treatment for SARS-CoV-2 variants -- Novel diagnostics methods for SARS-CoV-2 -- Microfluidic technologies for on-site detection and quantification of infectious diseases - the experience with SARS-CoV-2/COVID-19 -- Recent progressions on the colorimetric diagnosis of SARS-CoV-2 by Loop-Mediated Isothermal Amplification (LAMP) assay -- Bioinformatics study o the evolution of SARS-CoV-2 spike protein -- Real-time genomic surveillance for SARS-CoV-2 on center stage -- Emergency COVID-19 guidelines impacts on the human microbiome and immune system -- Ethics of using placebo controlled trials for COVID-19 vaccine development in vulnerable populations -- Tracking trails of SARS-CoV-2 - variants to therapy -- SARS-CoV-2 pandemic : how to maintain a COVID free hospital.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has probably been the most important disease to emerge in the 21st century. This viral zoonotic disease has been a significant cause of morbidity and mortality worldwide, but with a higher impact in low- and middle-income countries of Africa, Asia, and Latin America. Up to December 4, 2022, more than 645,195,564 cases had been reported globally, with 6,640,845 deaths, and more than 13,054,668,703 doses of a vaccine had been given. Research has been of the utmost importance in the COVID-19 crisis: a great deal of knowledge was gathered between December 2019 and December 2022. Appropriate evidence-based management and the development of safe and effective vaccines have been key to controlling the virus. This book presents a selection of the last two years' learning from research and clinical practice concerning SARS-CoV-2/COVID-19.

Electronic reproduction.: Knowledge Unlatched. Mode of access: World Wide Web.

Sustainable Development Goals Collection

Open Access

Powered by Koha